JP2001505768A5 - - Google Patents

Download PDF

Info

Publication number
JP2001505768A5
JP2001505768A5 JP1998524475A JP52447598A JP2001505768A5 JP 2001505768 A5 JP2001505768 A5 JP 2001505768A5 JP 1998524475 A JP1998524475 A JP 1998524475A JP 52447598 A JP52447598 A JP 52447598A JP 2001505768 A5 JP2001505768 A5 JP 2001505768A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998524475A
Other languages
English (en)
Other versions
JP4226657B2 (ja
JP2001505768A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB1997/001482 external-priority patent/WO1998023755A1/en
Publication of JP2001505768A publication Critical patent/JP2001505768A/ja
Publication of JP2001505768A5 publication Critical patent/JP2001505768A5/ja
Application granted granted Critical
Publication of JP4226657B2 publication Critical patent/JP4226657B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

Figure 2001505768
Figure 2001505768
Figure 2001505768
Figure 2001505768
Figure 2001505768
Figure 2001505768
Figure 2001505768
JP52447598A 1996-11-26 1997-11-26 診断、予防、及び治療のための、多発性硬化症に関連するウイルス性物質及びヌクレオチド断片 Expired - Lifetime JP4226657B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75642996A 1996-11-26 1996-11-26
US08/756,429 1996-11-26
PCT/IB1997/001482 WO1998023755A1 (en) 1996-11-26 1997-11-26 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes

Publications (3)

Publication Number Publication Date
JP2001505768A JP2001505768A (ja) 2001-05-08
JP2001505768A5 true JP2001505768A5 (ja) 2004-10-28
JP4226657B2 JP4226657B2 (ja) 2009-02-18

Family

ID=25043444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52447598A Expired - Lifetime JP4226657B2 (ja) 1996-11-26 1997-11-26 診断、予防、及び治療のための、多発性硬化症に関連するウイルス性物質及びヌクレオチド断片

Country Status (8)

Country Link
US (3) US6582703B2 (ja)
EP (1) EP0942987B1 (ja)
JP (1) JP4226657B2 (ja)
AT (1) ATE440141T1 (ja)
CA (1) CA2272845C (ja)
DE (1) DE69739544D1 (ja)
ES (1) ES2331496T3 (ja)
WO (1) WO1998023755A1 (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2272845C (en) * 1996-11-26 2010-01-12 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
FR2765588A1 (fr) * 1997-07-07 1999-01-08 Bio Merieux Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques
US20040176314A1 (en) * 1997-07-07 2004-09-09 Bio Merieux Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
DE19814925C2 (de) * 1998-04-03 2000-10-05 Thomas Harrer Arzneimittel zur Induktion zytotoxischer T-Zellen
FR2780069B1 (fr) * 1998-06-23 2002-06-28 Inst Nat Sante Rech Med Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
FR2788784A1 (fr) 1999-01-21 2000-07-28 Bio Merieux Fragment nucleique endogene associe a une maladie auto-immune, procede de marquage et reactif
EP1029917A1 (en) * 1999-02-15 2000-08-23 Bio Merieux The LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus
DE19921419A1 (de) 1999-05-08 2000-11-16 Univ Ruprecht Karls Heidelberg Verfahren zum spezifischen Nachweis und zur Identifizierung retroviraler Nukleinsäuren / Retroviren in einem Untersuchungsgut
JP2003507070A (ja) * 1999-08-20 2003-02-25 キュラジェン コーポレイション 活性化ｔリンパ球において発現される新規なポリヌクレオチドおよびそれによってコードされるタンパク質
FR2805279B1 (fr) * 2000-02-23 2004-09-24 Jean Jacques Guilhou Sequences retrovirales associees a des affections cutanees
US7442761B2 (en) * 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US7452963B2 (en) * 2001-03-27 2008-11-18 Samuel Bogoch Replikin peptides and antibodies therefore
US7774144B2 (en) * 2001-10-26 2010-08-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
US7189800B2 (en) * 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
KR100906102B1 (ko) * 2001-03-27 2009-07-07 사무엘 보고치 레플리킨 펩타이드 및 그의 이용
US8494781B2 (en) * 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
FR2863274B1 (fr) * 2003-12-05 2012-11-16 Commissariat Energie Atomique Procede d'evaluation quantitative d'un rearrangement ou d'une recombinaison genetique ciblee d'un individu et ses applications.
US9254315B2 (en) * 2004-04-28 2016-02-09 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
AU2007319669A1 (en) * 2006-05-30 2008-05-22 Elenore S. Bogoch Replikin peptides and uses thereof
EP2126140A4 (en) * 2007-01-18 2012-03-28 Samuel Bogoch METHOD FOR DETERMINING THE MORTALITY OF PATHOGENS AND MALIGNOMAS WITH REPLICINE TIPS
US20090269367A1 (en) * 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
US20100144589A1 (en) * 2008-08-08 2010-06-10 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
WO2010030931A1 (en) * 2008-09-11 2010-03-18 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Oligonucleotides targeting human endogenous retrovirus 9 (erv-9) long terminal repeat (ltr) and methods of use
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
FR2984360B1 (fr) * 2011-12-20 2017-11-24 Biomerieux Sa Procede pour le diagnostic ou le pronostic in vitro du cancer du colon
FR2984364A1 (fr) * 2011-12-20 2013-06-21 Biomerieux Sa Procede pour le diagnostic ou le pronostic in vitro du cancer de l'ovaire
WO2015085194A1 (en) * 2013-12-06 2015-06-11 The Broad Institute, Inc. Enhanced methods of ribonucleic acid hybridization
GB201509395D0 (en) * 2015-06-01 2015-07-15 Univ Leicester Improvements in and relating to nucleic acid probes

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871996A (en) 1994-02-04 1999-02-16 Bio Merieux Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis
WO1980000412A1 (en) 1978-08-24 1980-03-20 N Gilmour Pasteurellosis vaccines
US4311686A (en) 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
US4396600A (en) 1980-12-18 1983-08-02 Gus Gallucci Adult schistosome worm-derived antigenic substance and method of obtaining same
US4388298A (en) 1982-07-14 1983-06-14 The United States Of America As Represented By The Secretary Of Agriculture Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced
GB8324800D0 (en) 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4520113A (en) 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
US4647773A (en) 1984-04-23 1987-03-03 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
NZ218050A (en) 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
US4900553A (en) 1987-09-11 1990-02-13 Case Western Reserve University Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
EP0326395A2 (en) 1988-01-29 1989-08-02 City Of Hope Method of detecting and identifying certain viral sequences
FR2651581B1 (fr) 1989-09-06 1994-05-13 Centre Nal Recherc Scientifique Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.
US5219837A (en) 1990-06-21 1993-06-15 Trustees Of The University Of Pennsylvania Method of stimulating myelination of cells
US5158976A (en) 1990-10-29 1992-10-27 The Children's Medical Center Corporation Controlling glutamine/glutamate related neuronal injury
DK173091D0 (da) 1991-10-11 1991-10-11 Schleroseforeningen The Danish Biologisk materiale
FR2689520B1 (fr) 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
FR2689521B1 (fr) 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
EP0642585B1 (en) 1992-05-18 2005-12-28 Genentech, Inc. Activation of oligomerizing receptors by using fused receptor ligands
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus
FR2716198B1 (fr) 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
FR2731356B1 (fr) * 1995-03-09 1997-04-30 Bio Merieux Virus msrv-1 et agent pathogene et/ou infectant msrv-2 associes a la polyarthrite rhumatoide
FR2737500B1 (fr) * 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
CA2272845C (en) * 1996-11-26 2010-01-12 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes

Similar Documents

Publication Publication Date Title
JP2000501771A5 (ja)
JP2000517115A5 (ja)
JP2000501599A5 (ja)
JP2000501018A5 (ja)
JP2001512497A5 (ja)
JP2000501324A5 (ja)
JP2001502349A5 (ja)
JP2000501338A5 (ja)
JP2001500472A5 (ja)
JP2000500874A5 (ja)
JP2000502485A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2000500912A5 (ja)
JP2000501744A5 (ja)
JP2000511411A5 (ja)
JP2001506606A5 (ja)
JP2000500857A5 (ja)
JP2000501229A5 (ja)
JP2000502714A5 (ja)
JP2001505768A5 (ja)
JP2000514051A5 (ja)
JP2001502534A5 (ja)
JP2000500318A5 (ja)
JP2000506775A5 (ja)